0001144204-14-020145.txt : 20140402 0001144204-14-020145.hdr.sgml : 20140402 20140402115459 ACCESSION NUMBER: 0001144204-14-020145 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140402 DATE AS OF CHANGE: 20140402 EFFECTIVENESS DATE: 20140402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioPharma d'Azur, Inc. CENTRAL INDEX KEY: 0001604191 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-214723 FILM NUMBER: 14736901 BUSINESS ADDRESS: STREET 1: 1410 BROADWAY, 23RD FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10018 BUSINESS PHONE: 917-842-2353 MAIL ADDRESS: STREET 1: 1410 BROADWAY, 23RD FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10018 D 1 primary_doc.xml X0707 D LIVE 0001604191 BioPharma d'Azur, Inc. 1410 BROADWAY 23RD FLOOR NEW YORK NY NEW YORK 10018 917-842-2353 DELAWARE None None Corporation true 2014 Matthew Balk 1410 Broadway 23 Floor New York NY NEW YORK 10018 Executive Officer Director Biotechnology Decline to Disclose 06b false 2014-03-25 false true false 29150 1020250 385000 635250 false 4 0 0 0 false BioPharma d'Azur, Inc. /s/ Matthew Balk Matthew Balk President 2014-04-02